Symbol
TRAW on Nasdaq
Investment type
Equity - Shares of Stock
Class
Common Stock, par value $.01 per share
Latest Disclosed Ownership
761K shares
Security Ownership
19.9%
Shares, Excluding Options vs Price
Value, Excluding Options

ORBIMED ADVISORS LLC ownership in Traws Pharma, Inc. Common Stock, par value $.01 per share (TRAW)

2025-01-29 - ORBIMED ADVISORS LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 761K shares of Traws Pharma, Inc. Common Stock, par value $.01 per share (TRAW). This represents 19.9% percent ownership of the company.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.